Abstract:Emerging evidence suggests that GSK3β, a redox-sensitive transducer downstream of insulin signaling, acts as a convergent point for myriad pathways implicated in kidney injury, repair, and regeneration. However, its role in diabetic kidney disease remains controversial. In cultured glomerular podocytes, exposure to a milieu of type 2 diabetes elicited prominent signs of podocyte injury and degeneration, marked by loss of homeostatic marker proteins like synaptopodin, actin cytoskeleton disruption, oxidative stress and apoptosis, and stress-induced premature senescence, as shown by increased staining for senescence-associated β-galactosidase activity, amplified formation of γH2AX foci, and elevated expression of mediators of senescence signaling, like p21 and p16INK4A. These degenerative changes coincided with GSK3β hyperactivity, as evidenced by GSK3β overexpression and reduced inhibitory phosphorylation of GSK3β, and were averted by tideglusib, a highly-selective small molecule inhibitor of GSK3β. In agreement, post-hoc analysis of a publicly-available glomerular transcriptomics dataset from patients with type 2 diabetic nephropathy revealed that the curated diabetic nephropathy-related gene set was enriched in high GSK3β expression group. Mechanistically, GSK3β-modulated nuclear factor Nrf2 signaling is involved in diabetic podocytopathy, because GSK3β knockdown reinforced Nrf2 antioxidant response and suppressed oxidative stress, resulting in an improvement in podocyte injury and senescence. Conversely, ectopic expression of the constitutively active mutant of GSK3β impaired Nrf2 antioxidant response and augmented oxidative stress, culminating in an exacerbated diabetic podocyte injury and senescence. Moreover, IRS-1 was found to be a cognate substrate of GSK3β for phosphorylation at IRS-1S332, which negatively regulates IRS-1 activity. GSK3β hyperactivity promoted IRS-1 phosphorylation, denoting a desensitized insulin signaling. Consistently, in vivo in db/db mice with diabetic nephropathy, GSK3β was hyperactive in glomerular podocytes, associated with IRS-1 hyperphosphorylation, impaired Nrf2 response and premature senescence. Our finding suggests that GSK3β is likely a novel therapeutic target for treating type 2 diabetic glomerular injury.

Hyperglycemia - A culprit of podocyte pathology in the context of glycogen metabolism

Hyperglycemia alters mitochondrial respiration efficiency and mitophagy in human podocytes

The Redox-Sensitive GSK3β is a Key Regulator of Glomerular Podocyte Injury in Type 2 Diabetic Kidney Disease

The Histologic Disorders and Underlying Mechanisms of Podocytes During Diabetes

AMPK signalling: Implications for podocyte biology in diabetic nephropathy

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Ubiquitination and endoplasmic reticulum stress of renal intrinsic cells in hyperglycemia

Molecular and Cellular Events Mediating Glomerular Podocyte Dysfunction and Depletion in Diabetes Mellitus

Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction

High Glucose-Induced Ubiquitination of G6PD Leads to the Injury of Podocytes.

Crosstalk of Hyperglycaemia and Cellular Mechanisms in the Pathogenesis of Diabetic Kidney Disease

Glucose and Diabetes: Effects on Podocyte and Glomerular P38 MAPK, Heat-Shock Protein 25, and Actin Cytoskeleton

Emerging Protective Actions of PGC-1α in Diabetic Nephropathy

Compromised Glycolysis Contributes to Foot Process Fusion of Podocytes in Diabetic Kidney Disease: Role of Ornithine Catabolism.

Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity

Dihydroxyacetone phosphate accumulation leads to podocyte pyroptosis in diabetic kidney disease

Dysregulation of Low-Density Lipoprotein Receptor Contributes to Podocyte Injuries in Diabetic Nephropathy.

PKC-α Triggers EGFR Ubiquitination, Endocytosis and ERK Activation in Podocytes Stimulated with High Glucose

P2X7R/AKT/mTOR Signaling Mediates High Glucose-Induced Decrease in Podocyte Autophagy

Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease

Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects